Overview

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant

Status:
Completed

Trial end date:
2005-06-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to evaluate the safety and efficacy of equimolar conversion from MMF to enteric-coated mycophenolate sodium, in renal transplant patients receiving cyclosporine.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Mycophenolate mofetil
Mycophenolic Acid